PR
Insider
Paul D Rubin
Chief Medical OfficerPaul D Rubin (Chief Medical Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in BioAge Labs, Inc. (BIOA). The largest single filing was $702K of BIOA (68,897 sh × $10.19, as filed), executed Dec 4 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Apr 1
Filed Apr 3
Median ADV $8.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
BIOA
BioAge Labs, Inc.
BIOA · 0 buys · 5 sells
5 filings
Recent filings
BIOASALE
BioAge Labs, Inc.
View filing →
$157K8,820 sh × $17.81
Exec Apr 1
Filed Apr 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. View filing → $151K
7,433 sh × $20.30
Exec Mar 2
Filed Mar 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. View filing → $139K
7,433 sh × $18.75
Exec Feb 2
Filed Feb 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. View filing → $216K
18,000 sh × $12.00
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET BIOASALE BioAge Labs, Inc. View filing → $702K
68,897 sh × $10.19
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET